Search results for "Klebsiella pneumoniae"

showing 10 items of 80 documents

Variety of size and form of GRM2 bacterial microcompartment particles

2021

Bacterial microcompartments (BMCs) are bacterial organelles involved in enzymatic processes, such as carbon fixation, choline, ethanolamine and propanediol degradation, and others. Formed of a semi‐permeable protein shell and an enzymatic core, they can enhance enzyme performance and protect the cell from harmful intermediates. With the ability to encapsulate non‐native enzymes, BMCs show high potential for applied use. For this goal, a detailed look into shell form variability is significant to predict shell adaptability. Here we present four novel 3D cryo‐EM maps of recombinant Klebsiella pneumoniae GRM2 BMC shell particles with the resolution in range of 9 to 22 Å and nine novel 2D class…

chemistry.chemical_classification0303 health sciencesCryo-electron microscopyIcosahedral symmetryFull‐Length PapersCryoelectron Microscopy030302 biochemistry & molecular biologyCarbon fixationShell (structure)BiochemistryKlebsiella pneumoniae03 medical and health scienceschemistry.chemical_compoundEnzymeEthanolamineBacterial ProteinschemistryBacterial microcompartmentOrganelleBiophysicsMolecular Biology030304 developmental biologyProtein Science
researchProduct

Caracterización y tipificación molecular de cepas de Escherichia coli y Klebsiella pneumoniae productoras de betalactamasas de espectro extendido (BL…

2021

Introducción: Las betalactamasas de espectro extendido (BLEE) son enzimas producidas principalmente por la familia Enterobacteriaceae y se caracterizan porque inactivan a la práctica totalidad de los antibióticos betalactámicos. El aislamiento clínico de cepas productoras de BLEE es cada vez más frecuente en todo el mundo. Diferentes especies de Enterobacterales pueden ser productoras de BLEE, pero Klebsiella pneumoniae y Escherichia coli son las especies que las producen mayoritariamente. La realización de estudios de caracterización epidemiológica de las cepas productoras de BLEE es fundamental para detectar cualquier cambio en la resistencia y por tanto, para el control de su diseminació…

clonesescherichia coli bleebleeklebsiella pneumoniae bleeUNESCO::CIENCIAS MÉDICAS:CIENCIAS MÉDICAS [UNESCO]resistencia antibiótica
researchProduct

Severe Clostridium difficile infection with extremely high leucocytosis complicated by a concomitant bloodstream infection caused by Klebsiella pneum…

2020

Highlights • Exposure to antibiotics after surgery increase risk of Cl. difficile infection. • Sudden high leucocytosis may be sign of poor outcome in Cl. difficile case. • Oral Vancomycin could be responsible for the growth of bloodstream Kl. pneumonia.

medicine.medical_specialtyFulminantCefazolin03 medical and health sciences0302 clinical medicineVancomycinCase reportmedicineextremely high LeucocytosisSeptic shockbusiness.industryOsteomyelitisOsteomyelitisPseudomembranous colitisClostridium difficileClostridium difficilemedicine.diseaseSurgeryMetronidazoleKlebsiella pneumoniae030220 oncology & carcinogenesisVancomycin030211 gastroenterology & hepatologySurgerybusinessmedicine.drugInternational Journal of Surgery Case Reports
researchProduct

KPC - 3 Klebsiella pneumoniae ST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case seri…

2013

Background: Abdominal surgery carries significant morbidity and mortality, which is in turn associated with an enormous use of healthcare resources. We describe the clinical course of 30 Intensive Care Unit (ICU) patients who underwent abdominal surgery and showed severe infections caused by Klebsiella pneumoniae sequence type (ST) 258 producing K. pneumoniae carbapenemase (KPC-Kp). The aim was to evaluate risk factors for mortality and the impact of a combination therapy of colistin plus recommended regimen or higher dosage of tigecycline. Methods: A prospective assessment of severe monomicrobial KPC-Kp infections occurring after open abdominal surgery carried out from August 2011 to Augus…

medicine.medical_specialtyKlebsiella pneumoniae Carbapenemase Abdominal surgeryPeritonitisSettore MED/41 - AnestesiologiaAbdominal surgeryTigecyclinelaw.inventionCarbapenemaselawInternal medicineIntensive caremedicineSurgical emergencybusiness.industrymedicine.diseaseIntensive care unitSurgeryRegimenKlebsiella pneumoniaeAnesthesiology and Pain MedicineAbdominal surgery; Carbapenemase; Klebsiella pneumoniae; Anesthesiology and Pain MedicineColistinbusinessmedicine.drugAbdominal surgeryResearch ArticleBMC anesthesiology
researchProduct

Is the implementation of a microbiological surveillance screening beneficial in a neonatal intensive care unit?

2015

s of the 51st Workshop for Pediatric Research 51st Workshop for Pediatric Research Gottingen, Germany 16-17 April 2015 This supplement has not been sponsored. Meeting abstracts Background and aims Bacteria that cause nosocomial infections have often been found to colonize the patient's skin, respiratory tract or gastrointestinal tract previously. In 2012 and 2013, the German Commission for Hospital Hygiene and Infectious Disease Prevention recommended a microbiological screening of infants on neonatal intensive care units. Multidrug-resistant bacteria (MDR) that should be considered in empiric antibiotic therapy, bacteria that cause invasive infections and bacteria that may elicit epidemic …

medicine.medical_specialtyNeonatal intensive care unitbiologymedicine.drug_classbusiness.industryKlebsiella pneumoniaeeducationAntibioticsEnterobacterbiology.organism_classificationInfectious disease (medical specialty)Intensive careMeeting AbstractEpidemiologymedicineIntensive care medicinebusinessPathogenMolecular and Cellular Pediatrics
researchProduct

Genetic features of Multi Drug Resistant (MDR) Klebsiella pneumoniae and its Plasmids

2019

Klebsiella pneumoniae, a major cause of both hospital and community-acquired infections, is listed by the World Health Organization as a critical priority antibiotic- resistant bacterial pathogen. With the appearance of sequencing techniques such as Next-generation Sequencing (NGS), there is the possibility to obtain the whole genome of the bacteria, getting to know all antimicrobial resistance determinants. The purpose of this study has been to apply this new technology to clinical microbiology, in order to characterize the resistome present in carbapenem-resistant K.pneumoniae strains isolated in a tertiary hospital in Valencia, Spain. A total of 234 isolates were prepared for whole-genom…

medicine_pharmacology_otherPlasmidKlebsiella pneumoniaeMulti drug resistantBiologyAntimicrobialbiology.organism_classificationMicrobiology
researchProduct

Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study

2022

Abstract Objectives To explore the real-life performance of meropenem/vaborbactam for treating serious KPC-producing Klebsiella pneumoniae infections, including those resistant to ceftazidime/avibactam. Methods A retrospective observational cohort study was conducted in 12 Italian hospitals. Enrolled patients had K. pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-Kp) infections (59.5% of which were ceftazidime/avibactam resistant). Patients who received ≥72 h of meropenem/vaborbactam therapy (with or without other antimicrobials) in a compassionate-use setting were included. Results The 37 infections (all hospital-acquired) were mainly bacteraemic (BSIs, n = 23) or lower respira…

meropenemKPC-producing Klebsiella pneumoniae infectionMeropenem vaborbactamvaborbactam.
researchProduct

Isolation of Four Lytic Phages Infecting Klebsiella pneumoniae K22 Clinical Isolates from Spain

2020

This article belongs to the Special Issue Bacteriophage—Molecular Studies.

phage therapyPhage therapyPhage therapyKlebsiella pneumoniae<i>Klebsiella pneumoniae</i>medicine.medical_treatmentGenome ViralArticleHost SpecificityCatalysisMicrobiologylcsh:ChemistryInorganic ChemistryBacteriophageViral Proteins03 medical and health sciencesPodoviridaeProtein DomainsbacteriophagemedicineHumansBacteriophagesTypingPhysical and Theoretical ChemistryBacteriophagelcsh:QH301-705.5Molecular BiologyPhylogenySpectroscopy030304 developmental biologyWhole genome sequencingInfectivityLikelihood Functions0303 health sciencesbiology030306 microbiologyOrganic ChemistryGeneral Medicinebiology.organism_classification3. Good healthComputer Science ApplicationsKlebsiella pneumoniaelcsh:Biology (General)lcsh:QD1-999Lytic cycleSpainInternational Journal of Molecular Sciences
researchProduct

Double copies of blaKPC-3::Tn4401a on an IncX3 plasmid in Klebsiella pneumoniae successful clone ST512 from Italy

2015

ABSTRACT A carbapenem-resistant sequence type 512 (ST512) Klebsiella pneumoniae carbapenemase 3 (KPC-3)-producing K. pneumoniae strain showing a novel variant plasmid content was isolated in Palermo, Italy, in 2014. ST512 is a worldwide successful clone associated with the spread of bla KPC genes located on the IncFIIk pKpQIL plasmid. In our ST512 strain, the bla KPC-3 gene was unusually located on an IncX3 plasmid, whose complete sequence was determined. Two copies of bla KPC-3 ::Tn 4401a caused by intramolecular transposition events were detected in the plasmid.

transposonsequence analysispolymerase chain reactionDrug ResistanceGene DosageSettore MED/42 - Igiene Generale E Applicatabacterial proteinbeta-Lactamaseopen reading framecarbapenemasePlasmidminocyclineplasmid DNAmeropenemPharmacology (medical)geneticscolistincefpodoximeceftazidime610 Medicine &amp; healthCarbapenemBacterialpolymyxin Btimentingene expression regulationbacteriumKlebsiella pneumoniae carbapenemase 3 producing Klebsiella pneumoniae3. Good healthantiinfective agentmicrobial sensitivity testKlebsiella pneumoniaeItalypriority journaltigecyclineMultipleclone (Java method)cefotaxime030106 microbiologyKlebsiella pneumoniae carbapenemase 3tobramycinMicrobial Sensitivity Testsgentamicinpiperacillin plus tazobactamchemistryGene dosageArticleMicrobiology03 medical and health sciencesComplete sequenceClone CellOpen Reading FramesertapenemBacterial Proteinsmultidrug resistanceextensively drug resistant bacteriumAnti-Bacterial AgentcefepimePharmacologylevofloxacinmicrobiologycefoxitinbiochemical phenomena metabolism and nutritionbacterial infections and mycosesVirologyAnti-Bacterial Agents; Bacterial Proteins; Carbapenems; Clone Cells; Drug Resistance Multiple Bacterial; Gene Dosage; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Open Reading Frames; Plasmids; beta-Lactamases; DNA Transposable Elements; Gene Expression Regulation Bacterial; Pharmacology (medical); Pharmacology; Infectious Diseasesantibiotic sensitivityClone CellsKlebsiella InfectionsceftriaxoneCarbapenemsbacterial genetics0301 basic medicinemolecular cloningSettore MED/07 - Microbiologia E Microbiologia ClinicaKlebsiella pneumoniaeTransposition (music)Drug Resistance Multiple Bacterialpolycyclic compoundsgenetic screeningcell clonecarbapenem derivativeKlebsiella infectionunclassified drugAnti-Bacterial AgentsInfectious Diseasesbacterial genePlasmidsenzymologydoripenemBiologyminimum inhibitory concentrationbeta-Lactamasesbeta lactamaseMechanisms of ResistanceciprofloxacinAmikacin; aztreonam; carbapenemase; cefepime; cefotaxime; cefoxitin; cefpodoxime; ceftazidime; ceftriaxone; ciprofloxacin; colistin; cotrimoxazole; doripenem; doxycycline; ertapenem; gentamicin; imipenem; Klebsiella pneumoniae carbapenemase 3; levofloxacin; meropenem; minocycline; piperacillin plus tazobactam; plasmid DNA; polymyxin B; tigecycline; timentin; tobramycin; unclassified drug; antiinfective agent; bacterial protein; beta lactamase; carbapenem derivative; transposon antibiotic sensitivity; Article; bacterial gene; bacterial genetics; bacterial strain; bacterium; bacterium detection; bacterium isolation; Escherichia coli; extensively drug resistant bacterium; gene dosage; genetic screening; Italy; Klebsiella pneumoniae; Klebsiella pneumoniae carbapenemase 3 producing Klebsiella pneumoniae; minimum inhibitory concentration; molecular cloning; nonhuman; polymerase chain reaction; priority journal; sequence analysis; cell clone; chemistry; drug effects; enzymology; gene expression regulation; genetics; isolation and purification; Klebsiella infection; Klebsiella pneumoniae; metabolism; microbial sensitivity test; microbiology; multidrug resistance; open reading frame; plasmid; transposon Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Clone Cells; DNA Transposable Elements; Drug Resistance Multiple Bacterial; Gene Dosage; Gene Expression Regulation Bacterial; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Open Reading Frames; Plasmidsplasmidbacterium isolationEscherichia coliGeneAmikacinbacterium detectionnonhumandoxycyclineisolation and purificationGene Expression Regulation Bacterialbiology.organism_classificationbacterial straincotrimoxazoleOpen reading frameDNA Transposable Elementdrug effectsDNA Transposable Elementsmetabolismaztreonamimipenem
researchProduct

Systematic Comparison of Epidemic and Non-Epidemic Carbapenem Resistant Klebsiella pneumoniae Strains

2021

Over the past few decades, extensively drug resistant (XDR) resistant Klebsiella pneumoniae has become a notable burden to healthcare all over the world. Especially carbapenemase-producing strains are problematic due to their capability to withstand even last resort antibiotics. Some sequence types (STs) of K. pneumoniae are significantly more prevalent in hospital settings in comparison to other equally resistant strains. This provokes the question whether or not there are phenotypic characteristics that may render certain K. pneumoniae more suitable for epidemic dispersal between patients, hospitals, and different environments. In this study, we selected seven epidemic and non-epidemic ca…

virulenceantibiotic resistanceextended-spectrum beta-lactamaselcsh:QR1-502XDR Klebsiella pneumoniaeepidemiclcsh:MicrobiologyFrontiers in Cellular and Infection Microbiology
researchProduct